Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arginine Therapy for Acute Chest Syndrome in Sickle Cell Disease
NCT00029731Phase 2Completed
- Sponsor
- UCSF Benioff Children's Hospital Oakland
- Start
- Aug 2001
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of arginine in acute chest syndrome (ACS) (3 arms), sponsored by UCSF Benioff Children's Hospital Oakland. Primary endpoint: Increase in Nitric Oxide Production at 3 days. Started Aug 2001; status: completed.
02
Drugs
arginine
03
Conditions
acute chest syndrome (ACS)
Beyond the preview
Go deeper on NCT00029731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00029731.